Insurers won't cover new Alzheimer's treatment for some customers
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s pati...
Search by tag: alzheimer
Second Alzheimer's drug in the pipeline promises to slow worsening but with safety concern
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use
U.S. health advisers are backing the full approval of an Alzheimer's drug that received preliminary approval last year
Eli Lilly says experimental drug slows Alzheimer's worsening
Eli Lilly and Co. says its experimental Alzheimer's drug appears to slow worsening of the mind-robbing disease
Lauder family pledges $200M to its Alzheimer's research work
The sons of cosmetics giant Estée Lauder, along with her four grandchildren, pledged $200 million Tuesday to the Alzheim...
Seeking Alzheimer's clues from few who escape genetic fate
Scientists are digging into why a few people escape the rarest form of Alzheimer's, which is inherited and strikes young
Why a new Alzheimer's drug is having a slow US debut
The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months awa...
Alzheimer's drug shows promise in early results of study
Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. sai...
Biogen cuts the price tag on its Alzheimer's drug in half
Biogen is slashing the price of its Alzheimer’s treatment months after the drug debuted to widespread criticism for an i...
Alzheimer's drug cited as Medicare premium jumps by $21.60
Medicare’s “Part B” outpatient premium will jump by $21.60 next year, one of the largest increases ever
